MRes Experimental Medicine (Cancer) Program By The University of Manchester |Top Universities

MRes Experimental Medicine (Cancer)

MRes Experimental Medicine (Cancer)

  • QS World University Rankings
    27
  • Degree MRes
  • Study Level Masters
  • Duration 36 months
  • Start date Jan-2000
The MRes Experimental Medicine (Cancer) programme will give nurses, doctors, clinical researchers and clinical trials co-ordinators the skills needed to work in early phase clinical studies. On this course, students will learn how to master experimental medicine with a focus on cancer through a combination of traditional teaching and hands-on learning, through spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units. The taught units will cover the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing. Alongside the taught elements, each student will be allocated to one or more clinical trials that are being conducted by The Christie Experimental Cancer Medicine team. Each student will have a named supervisor and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study. Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients. For clinical trial coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research. Students can choose two aspects of their direct clinical trial research experience to write up for their two research projects in a dissertation format.
English language Test